The surface glycopeptidolipids of mycobacteria: Structures and biological properties

Cellular and Molecular Life Sciences

Volumn 58, Issue 14, 2001, Pages 2018-2042

  Chatterjee, D ^a   Khoo, K H ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

Glycopeptidolipid (GPL); Haptenic oligosaccharides; Mycobacteria; Mycobacterium avium complex (MAC); Neoglycoproteins

Indexed keywords

EPITOPE; GLYCOLIPID; GLYCOPEPTIDASE; GLYCOPEPTIDOLIPID; HAPTEN; NEOGLYCOPROTEIN; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIGENICITY; BACTERIAL CELL WALL; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE; MYCOBACTERIUM INTRACELLULARE;

EID: 0035660384     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000834     Document Type: Review

References (155)

1. Multifactorial nature of human immunodeficiency virus disease: Implications in therapy
2. Pathology of Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome
3. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome
4. Isolation of M. avium complex from water in the United States, Finland, Zaire and Kenya
5. Persistent colonization of potable water as a source of Mycobacterium avium infection in AIDS
6. Mycobacteria in oil and their relation to disease-associated strains
7. Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome
8. Concentration of Mycobacterium avium by hospital hot water systems
9. Epidemeology of Mycobacterium avium complex
10. Risk assessment of opportunistic bacterial pathogens in drinking water
11. Mycobacterial Infection in AIDS pateints, with an emphasis on the Mycobacterium avium complex
12. Impact of opportunistic disease on survival in patients with HIV infection
13. Mycobacterium avium complex in water, food and soil samples collected from the environment of HIV-infected individuals
14. The anatomy of mycobacteria
15. Lipids: Complex lipids, their chemistry, biosynthesis and roles
16. The envelope of mycobacteria
17. Mycosides: A new class of type specific glycolipids of mycobacteria
18. Mycobacterium and other actinomycetes
19. The variable surface glycolipids of mycobacteria: Structures, synthesis of epitopes and biological properties
20. Detection of specific lipids in mycobacteria by infrared spectroscopy
21. The characterization of mycobacterial strains by composition of their lipid extracts
22. Serologic identification and classification of the atypical mycobacteria by their agglutination
23. Identification and incidence of a third type of Mycobacterium avium
24. Thin-layer chromatography of mycobacterial lipids as an aid to classification: Technical improvements: Mycobacterium avium M. intracellulare (Battey bacilli)
25. Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria
26. Structure of a peptidolipid glycoside isolated from a Mycobacterium
27. N-methylation of peptides by the method of Hakomori. Structure ofmycoside Cbl
28. Structural studies on the type-specific antigens and lipids of the Mycobacterium avium-Mycobacterium intracellulare Mycobacterium scrofulaceum complex serocomplex
29. Structures of the glycopeptidolipid antigens from serovars in the Mycobacterium avium/Mycobacterium intracellulare/Mycobacterium scrofulaceum serocomplex
30. Mycobacterium szulgai - A new pathogen. Serologic identification and report of five new cases
31. Trehalose-containing lipooligosaccharides. A new class of species-specific antigens from Mycobacterium
32. Pyruvylated glycolipids from Mycobacterium smegmatis: Structures of two oligosaccharide components
33. Pyruvylated glycolipids from Mycobacterium smegmatis. Nature and location of the lipid components
34. Correlation of biologic properties of strains of Mycobacterium with infrared spectrum III: Differentiation of bovine and human varieties of M. tuberculosis by means of infra red spectrum
35. Infrared spectroscopy in bacteriological research
36. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity
37. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae
38. Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals
39. Dealkylation
40. Determination of D and L configuration of neutral monosaccharides by high-resolution capillary GLC
41. Assignment of absolute configuration of sugars by g.l.c. of their acetylated glycosides formed from chiral alcohols
42. N-formylkansosaminyl-(1 → 3)-2-O-methyl-D-hamnopyranose: The type-specific determinant of serovariant 14 of the Mycobacterium avium complex
43. The presence of novel glucuronic acid-containing, type-specific glycolipid antigens within Mycobacterium spp. Revision of earlier structures
44. Glucuronic acid- and branched sugar-containing glycolipid antigens of Mycobacterium avium
45. Structures of the glycopeptidolipid antigens of serovars 25 and 26 of the Mycobacterium avium serocomplex, synthesis of allyl glycosides of the outer disaccharide units and serology of the derived neoglycoproteins
46. Degradation of polysaccharides containing uronic acid residues
47. Gas-liquid chromatography and mass spectrometry in methylation analysis of polysaccharides
48. A rapid permethylation of glycolipid, and polysaccharide catalysed by methylsulfinyl carbanion in dimethylsulfoxide
49. A simple and rapid method for the permethylation of carbohydrates
50. Methylation of carbohydrates by methyl trifluoromethanesulfonate in trimethyl phosphate
51. F.A.B.-mass spectrometry of carbohydrates
52. Plasma desorption mass spectrometric analysis of mycobacterial glycolipids
53. Novel O-methylated terminal glucuronic acid characterizes the polar glycopeptidolipids of Mycobacterium habana strain TMC 5135
54. Structural definition of the glycopeptidolipids and the pyruvylated, glycosylated acyltrehalose from Mycobacterium butyricum
55. Mycobacterial glycolipids: Isolation, structures, antigenicity and synthesis of neoantigens
56. 1H NMR ROESY for structural determination of O-glycosylated amino acids from a serine-containing glycopeptidolipid antigen
57. Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex
58. Structure of the glycopeptidolipid antigen of serovar 20 of the Mydobacterium avium serocomplex, synthesis of allyl glycosides of the outer di- and tri-saccharide untis of the antigens of serovars 14 and 20, and serology of the derived neoglycoproteins
59. Further novel amido sugars within the glycopeptidolipid antigens of Mycobacterium avium
60. A glycolipid antigen specific to Mycobacterium paratuberculosis: Structure and antigenicity
61. Structure and antigenicity of the specific oligosaccharide hapten from the glycopeptidolipid antigen of Mycobacterium avium serotype 4, the dominant Mycobacterium isolated from patients with acquired immune deficiency syndrome
62. Mycobacterium habana, a new immunogenic strain in experimental tuberculosis of mice
63. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad
64. Immunoreactive antigens of a candidate leprosy vaccine: Mycobacterium habana
65. Lymphostimulatory and delayed-type hypersensitivity responses to a candidate leprosy vaccine strain: Mycobacterium habana
66. Identification of a methyltransferase from Mycobacterium smegmatis involved in glycopeptidolipid synthesis
67. Antigenic relationships of the Mycobacterium chelonae complex
68. Structures of the glycopeptidolipid antigens of Mycobacterium abcessus and Mycobacterium chelonae and possible chemical basi of serological cross-reactions in the Mycobacterium fortuitum complex
69. Glycopeptidolipids from Mycobacterium fortuitum: A variant in the structure of C-mycoside
70. Structure of a novel sulfate-containing mycobacterial glycolipid
71. Structures of the glycopeptidolipid antigens of two animal pathogens: Mycobacterium senegalense and Mycobacterium porcinum
72. Characterization of the specific antigenicity of representatives of M. senegalense and related bacteria
73. A new type of serine-containing glycopeptidolipid from Mycobacterium xenopi
74. Further structural definition of a new family of glycopeptidolipids from Mycobacterium xenopi
75. 13C-NMR assignment
76. Generation of monoclonal antibodies to the specific sugar epitopes of Mycobacterium avium complex serovars
77. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy
78. General synthesis of model glycoproteins - Coupling of alkenyl-glycosides to proteins, using redutive ozonolysis followed by reductive amination with sodium cyanoborohydride
79. Synthesis of allyl glycosides for conversion into neoglycoproteins bearing epitopes of mycobacterial glycolipid antigens
80. Thioglycosides as glycosyl donors in oligosaccharide synthesis
81. A stereoselective synthesis of pyruvic 4,6-acetals of D-hexopyranose residues
82. A greatly improved procedure for ruthenium tetraoxide catalyzed oxidations of organic-compounds
83. Formation, structure and synthetic use of glucopyranoside and galactopyranoside acetophenone acetals with 1,3-dioxane rings
84. Synthesis of phenyl 4-(N-benzylformamido)-4,6-dideoxy-3-C-methyl-2-O-methyl-1-thio-α- L-mannopyranoside, an N-formylkansosamine glycosyl donor
85. Synthesis of branched-chain sugars - Stereoselective route to sibirosamine, kansosamine and vineloe from a common precursor
86. Regioselective reductive ring-opening of 4-methoxybenzylidene acetals of hexopyranosides - Access to a novel protecting group strategy
87. Synthesis of carbohydrate-containing surface antigens of mycobacteria
88. A stereoconvergent synthesis of the oligosaccharide segment of glycopeptidolipid antigen of Mycobacterium avium serotype-4 - A dominant serovariant observed in patients with acquired immune-deficiency syndrome
89. Synthesis of Me α-L-Rhap-(1-])-2-O-Me-α-L-Rhap and Me 2,3,4-Tri-O-Me-αL-Fucp-(1-]3)-α-L-Rhap-(1-]3)-2-O-Me- α-L-Rhap - Oligosaccharide segments of phenolic glycolipids in Mycobacterium bovis Bcg and tuberculosis strain Canetti
90. Iodonium ion-assisted synthesis of a haptenic tetrasaccharide fragment corresponding to the inner cell wall glycopeptidolipid of Mycobacterium avium serotype-4
91. Synthesis of P-trifluoroacetamidophenyl 6-deoxy-2-O-(3-0-[2-0-methyl-3-0-(2-0-methyl-α-D-rhamnopyranosyl)- α-L-fucopyranosyl]-α-L-Rhamnopyranosyl)-α-L-talopyranoside - A spacer armed tetrasaccharide glycopeptidolipid antigen of Mycobacterium-Avium serovar 20
92. Thioglycosides as glycosylating agents in oligosaccharide synthesis
93. Synthesis of the species-specific Mycobacterium avium trisaccharide (serovar-21) for the preparation of a neoglycoprotein for immunological studies
94. Intramolecular glycosylation of prearranged glycosides. A novel tool for controlling the reactivity and anomeric selectivity of glycosylations
95. Synthesis of 5-aminopentyl monosaccharide to trisaccharide haptens related to the species-specific glycopeptidolipids of Mycobacterium avium intracellulare serovar-8 and serovar-21
96. Synthesis of p-trifluoroacetamidophenyl(4,6-dideoxy-4-formamido-3-C-methyl-2-O-methyl -α-L-mannopyranosyl)-(1-3)-(2-)-methyl-α-D-rham nopyranosyl-(1-3)-(2-O-methyl-α-L-fucopyranosyl)-(1-3)-(α-L- rhamnopyranosyl) (1-2)-6-deoxy-α-L-talopyranoside
97. Synthesis of methyl 3-O-[3-O-(2,3,4-Tri-O-methyl-α-L-rhamnopyranosyl)-α-L- rhamnopyranosyl]-α-L-rhamnopyranoside - The outer trisaccharide unit of a unique Mycobacterium xenopi glycopeptidolipid
98. Synthesis of the glycopeptide O-(3,4-Di-O-methyl-2-O-[3,4-Di-O-methyl-α-L-rhamnopyranosyl] -α-L-rhamnopyranosyl)-L-alaninol - An unusual part structure in the glycopeptidolipid of Mycobacterium fortuitum
99. Synthesis of a new serine containing glycotetrapeptide from Mycobacterium xenopi glycopeptidolipid: An unusual structural variant in Mycobacterium genus
100. Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection
101. The mycoside capsule of Mycobacterium avium
102. Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens
103. Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamallar structure: Freeze fracture analysis of infected mouse liver
104. Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8
105. Role of Th1 and Th2 cells in bacterial infections
106. Cytokine circuits in tuberculosis
107. Human Th1 and Th2 subsets: Doubt no more
108. Induction nd expression of protective T cells during Mycobacterium avium infections in mice
109. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice
110. Animal and cell-culture models for the study of mycobacterial infections and treatment
111. Role of gamma interferon and tumor necrosis factor alpha during T-cell independent and dependent phases of Mycobacterium avium infection
112. Pathogenesis of human immunodeficiency virus infection
113. Exposure of human peripheral blood mononuclear cells to total lipids and serovar-specific glycopeptidolipids from Mycobacterium avium serovars 4 and 8 results in inhibition of TH1-type responses
114. Immunological and ultrastructural disruptions of T lymphocytes following, exposure to the glycopeptidolipid isolated from the Mycobacterium avium complex
115. Processing of mycobacterial lipids and effects on host responsiveness
116. Mycobacterial glycopeptidolipid interactions with membranes: A monolayer study
117. Effect of serotype specific glycopeptidolipid (GPL) isolated from Mycobacterium avium complex (MAC) on phagocytosis and phagosome-lysosome fusion of human peripheral blood monocytes
118. Adjuvant activity of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on the immunogenic and protective effects of an inactivated influenza vaccine
119. Immunostimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae for inactivated rabies vaccine
120. Effects of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on granulomacrophage progenitors
121. Stimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae on murine haematopoietic stem cells and megakaryocyte progenitors
122. Mycobacterial polar glycopeptidolipids enhance resistance to experimental murine candidiasis
123. Description of various colony forms of mycobacteria
124. Differential colony characteristics of mycobacteria on Middlebrook and Cohn 7H10 agar base medium
125. Spontaneous and induced mutations in Mycobacterium avium
126. Effects of temperature on the rate of the transparent to opaque colony type transition in Mycobacterium avium
127. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome
128. Analysis of plasmids in Mycobacterium avium intracellulare isolates from persons with acquired immunodeficiency syndrome
129. Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacterium avium
130. Immunopathogenesis of Mycobacterium avium infection
131. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor
132. Specific surface antigens of SmT variants of Mycobacterium avium
133. Mycobacterium
134. Postphagocytic detection of glycopeptidolipids associated with the superficial L1 layer of Mycobacterium intracellulare
135. Molecular basis of colony morphology in Mycobacterium avium
136. Bacterial surface translocation: A survey and classification
137. Sliding motility in mycobacteria
138. Genetic analysis of sliding motility in Mycobacterium smegmatis
139. Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium
140. Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression
141. A genetic mechanism for deletion of the ser2 gene cluster and formation of rough morphological variants of Mycobacterium avium
142. Biosynthesis and assembly of bacterial cell walls
143. Biosynthesis of peptide antibiotics
144. Studies on clofazimine resistance in mycobacteria: Is the inability to isolate drug-resistance mutants related to its mode of action?
145. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi
146. Identification of a peptide synthetase involved in the biosynthesis of glycopeptidolipids of Mycobacterium smegmatis
147. Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium
148. Isolation, characterization and expression in Escherichia Coli of the Pseudomonas aeruginosa rhlAB genes encoding a rhamnosyltransferase involved in the rhamnolipid biosurfactant synthesis
149. Glycosyl transferases of O-antigen biosynthesis in Salmonella enterica: Identification and characterization of transferase genes of groups B
150. Identification and characterization of the dTDP-rhamnose biosynthesis and transfer genes of the lipopolysaccharide-related rrb locus in Leptospira interrogans serovar Copenhageni
151. Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster
152. Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids